Myeloid growth factors, version 2.2017

Jeffrey Crawford; Pamela Sue Becker; James O. Armitage; Douglas W. Blayney; Julio Chavez; Peter Curtin; Shira Dinner; Thomas Fynan; Ivana Gojo; Elizabeth A. Griffiths; Shannon Hough; Dwight D. Kloth; David J. Kuter; Gary H. Lyman; Mary Mably; Sudipto Mukherjee; Shiven Patel; Lia E. Perez; Adam Poust; Raajit Rampal; Vivek Roy; Hope S. Rugo; Ayman A. Saad; Lee S. Schwartzberg; Sepideh Shayani; Mahsa Talbott; Saroj Vadhan-Raj; Sumithira Vasu; Martha Wadleigh; Peter Westervelt; Jennifer L. Burns; Lenora Pluchino

doi:10.6004/jnccn.2017.0175

Myeloid growth factors, version 2.2017

Jeffrey Crawford
, Pamela Sue Becker
, James O. Armitage
, Douglas W. Blayney
, Julio Chavez
, Peter Curtin
, Shira Dinner
, Thomas Fynan
, Ivana Gojo
, Elizabeth A. Griffiths
, Shannon Hough
, Dwight D. Kloth
, David J. Kuter
, Gary H. Lyman
, Mary Mably
, Sudipto Mukherjee
, Shiven Patel
, Lia E. Perez
, Adam Poust
, Raajit Rampal

Vivek Roy, Hope S. Rugo, Ayman A. Saad, Lee S. Schwartzberg, Sepideh Shayani, Mahsa Talbott, Saroj Vadhan-Raj, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, Jennifer L. Burns, Lenora Pluchino

Office of Research Compliance

Duke University
Seattle Cancer Care Alliance
University of Nebraska Medical Center
Stanford University
Moffitt Cancer Center
University of California at San Diego
Northwestern University
Yale University
Johns Hopkins University
University of Michigan, Ann Arbor
Fox Chase Cancer Center
Massachusetts General Hospital Cancer Center
University of Wisconsin-Madison
Case Western Reserve University
University of Utah
University of Colorado Anschutz Medical Campus
Memorial Sloan-Kettering Cancer Center
Mayo Clinic Rochester, MN
University of California at San Francisco
University of Alabama at Birmingham
University of Tennessee Health Science Center
City of Hope National Med Center
Vanderbilt University
University of Texas MD Anderson Cancer Center
Ohio State University
Dana-Farber
Washington University St. Louis

Research output: Contribution to journal › Review article › peer-review

127 Scopus citations

Abstract

Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

Original language	English
Pages (from-to)	1520-1541
Number of pages	22
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2017.0175
State	Published - Dec 1 2017

Access to Document

10.6004/jnccn.2017.0175

Cite this

Crawford, J., Becker, P. S., Armitage, J. O., Blayney, D. W., Chavez, J., Curtin, P., Dinner, S., Fynan, T., Gojo, I., Griffiths, E. A., Hough, S., Kloth, D. D., Kuter, D. J., Lyman, G. H., Mably, M., Mukherjee, S., Patel, S., Perez, L. E., Poust, A., ... Pluchino, L. (2017). Myeloid growth factors, version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network, 15(12), 1520-1541. https://doi.org/10.6004/jnccn.2017.0175

@article{8b9c3e0516bf4fb49765d1781a5b8937,

title = "Myeloid growth factors, version 2.2017",

abstract = "Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.",

author = "Jeffrey Crawford and Becker, \{Pamela Sue\} and Armitage, \{James O.\} and Blayney, \{Douglas W.\} and Julio Chavez and Peter Curtin and Shira Dinner and Thomas Fynan and Ivana Gojo and Griffiths, \{Elizabeth A.\} and Shannon Hough and Kloth, \{Dwight D.\} and Kuter, \{David J.\} and Lyman, \{Gary H.\} and Mary Mably and Sudipto Mukherjee and Shiven Patel and Perez, \{Lia E.\} and Adam Poust and Raajit Rampal and Vivek Roy and Rugo, \{Hope S.\} and Saad, \{Ayman A.\} and Schwartzberg, \{Lee S.\} and Sepideh Shayani and Mahsa Talbott and Saroj Vadhan-Raj and Sumithira Vasu and Martha Wadleigh and Peter Westervelt and Burns, \{Jennifer L.\} and Lenora Pluchino",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2017",

month = dec,

day = "1",

doi = "10.6004/jnccn.2017.0175",

language = "English",

volume = "15",

pages = "1520--1541",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "12",

}

Crawford, J, Becker, PS, Armitage, JO, Blayney, DW, Chavez, J, Curtin, P, Dinner, S, Fynan, T, Gojo, I, Griffiths, EA, Hough, S, Kloth, DD, Kuter, DJ, Lyman, GH, Mably, M, Mukherjee, S, Patel, S, Perez, LE, Poust, A, Rampal, R, Roy, V, Rugo, HS, Saad, AA, Schwartzberg, LS, Shayani, S, Talbott, M, Vadhan-Raj, S, Vasu, S, Wadleigh, M, Westervelt, P, Burns, JL & Pluchino, L 2017, 'Myeloid growth factors, version 2.2017', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 12, pp. 1520-1541. https://doi.org/10.6004/jnccn.2017.0175

TY - JOUR

T1 - Myeloid growth factors, version 2.2017

AU - Crawford, Jeffrey

AU - Becker, Pamela Sue

AU - Armitage, James O.

AU - Blayney, Douglas W.

AU - Chavez, Julio

AU - Curtin, Peter

AU - Dinner, Shira

AU - Fynan, Thomas

AU - Gojo, Ivana

AU - Griffiths, Elizabeth A.

AU - Hough, Shannon

AU - Kloth, Dwight D.

AU - Kuter, David J.

AU - Lyman, Gary H.

AU - Mably, Mary

AU - Mukherjee, Sudipto

AU - Patel, Shiven

AU - Perez, Lia E.

AU - Poust, Adam

AU - Rampal, Raajit

AU - Roy, Vivek

AU - Rugo, Hope S.

AU - Saad, Ayman A.

AU - Schwartzberg, Lee S.

AU - Shayani, Sepideh

AU - Talbott, Mahsa

AU - Vadhan-Raj, Saroj

AU - Vasu, Sumithira

AU - Wadleigh, Martha

AU - Westervelt, Peter

AU - Burns, Jennifer L.

AU - Pluchino, Lenora

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

AB - Myeloid growth factors (MGFs) are given as supportive care to patients receiving myelosuppressive chemotherapy to reduce the incidence of neutropenia. This selection from the NCCN Guidelines for MGFs focuses on the evaluation of regimenand patient-specific risk factors for the development of febrile neutropenia (FN), the prophylactic use of MGFs for the prevention of chemotherapy-induced FN, and assessing the risks and benefits of MGF use in clinical practice.

UR - https://www.scopus.com/pages/publications/85038445478

U2 - 10.6004/jnccn.2017.0175

DO - 10.6004/jnccn.2017.0175

M3 - Review article

C2 - 29223990

AN - SCOPUS:85038445478

SN - 1540-1405

VL - 15

SP - 1520

EP - 1541

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 12

ER -

Myeloid growth factors, version 2.2017

Abstract

Access to Document

Other files and links

Fingerprint

Cite this